基于贪心算法的宫颈癌非共面插植近距离放疗半自动轨迹规划方法
该研究提出基于贪心算法的针道轨迹规划框架(GANTP),用于宫颈癌3D打印辅助插植近距离放疗,在20例患者CT数据上生成无碰撞、患者特异性针道配置。与手动计划相比,最终选定方案HR-CTV覆盖率达91.96±1.24%,满足临床阈值,OAR剂量无显著差异,平均针数从5.40±0.94降至4.25±0.55,计划流程时间从2–3小时缩短至8.2±1.4分钟。
要点
- GANTP可为全部20例患者生成临床可接受计划,HR-CTV覆盖率达91.96±1.24%。
- 最终选定方案平均针数4.25±0.55,显著低于手动计划的5.40±0.94(P<0.001)。
- 计划流程时间从2–3小时缩短至8.2±1.4分钟,算法执行小于190秒。
核心结论
- GANTP可半自动生成无碰撞、患者特异性非共面针道轨迹,满足临床剂量目标并减少平均针数。
研究设计与样本
- 方法学研究,基于贪心算法的针道轨迹规划框架,使用20例宫颈癌患者CT数据集评估,与手动计划对比。
主要发现
- GANTP为全部20例生成临床可接受计划,最终选定方案HR-CTV覆盖率达91.96±1.24%,手动计划为92.62±1.51%(P=0.024)。
- 直肠D2cc为66.11±3.99 Gy vs. 66.46±4.00 Gy(P=0.542),膀胱为78.28±5.16 Gy vs. 79.45±4.47 Gy(P=0.201),乙状结肠为63.30±4.86 Gy vs. 62.33±6.84 Gy(P=0.916),OAR受量无显著差异。
- 平均针数从5.40±0.94降至4.25±0.55(P<0.001),一例患者针数从7降至4且覆盖率维持91.7%。
- 计划流程时间从2–3小时(手动)缩短至8.2±1.4分钟,算法执行在所有δ设置下小于190秒。
关键数值与推荐
- 几何影响半径δ取12、15、18 mm三个离散值,几何覆盖率阈值γ=98%,并设相对宫腔管的无碰撞余量d。
- 最终选择策略优先临床可接受HR-CTV覆盖率(≥90%)并在评估的δ设置中选择最低针数,16例选δ=15 mm,4例选δ=18 mm。
临床怎么用
- 可与3D打印模板整合,用于宫颈癌插植近距离放疗的半自动针道规划,减少针数并缩短计划时间。
局限性
- 研究基于20例患者CT数据集,未来需开展体模实验进行物理验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Precise spatial distribution of interstitial needles is critical for 3D-printing-assisted brachytherapy in cervical cancer. This study proposes a greedy algorithm-based needle trajectory planning (GANTP) framework to generate patient-specific needle configurations while ensuring needle collision avoidance and achieving clinically acceptable high-risk clinical target volume (HR-CTV) coverage in compliance with OAR dose constraints. METHODS AND MATERIALS: The GANTP framework comprises three core steps: (1) Generation of candidate trajectories anchored within clinically viable entry zones; (2) Parameter-driven greedy selection of needle trajectories based on a geometric influence radius (δ) evaluated at three discrete values (12, 15, and 18 mm), where δ serves as a geometric surrogate for dose coverage, together with a geometric coverage-ratio threshold (γ = 98%) and a collision-free margin (d) relative to the tandem; and (3) Dosimetric evaluation and inverse planning with dwell-time optimization. The framework was evaluated using CT datasets from 20 cervical cancer patients. Performance metrics, including HR-CTV coverage, organs-at-risk (OAR) doses (D2cc), needle counts, and efficiency, were compared against manual planning. RESULTS: GANTP was able to generate clinically acceptable plans for all 20 cases. Based on a final-selection strategy that prioritized clinically acceptable HR-CTV coverage (≥ 90%) and the lowest needle count among the evaluated δ settings, δ = 15 mm was selected for 16 patients and δ = 18 mm for 4 patients as the final selected configurations. Compared to manual planning (HR-CTV coverage: 92.62 ± 1.51%), these Final Selected plans achieved clinically acceptable coverage of 91.96 ± 1.24% (P = 0.024), consistently exceeding the 90% clinical threshold. The OAR sparing was no significant difference to manual planning: D2cc for the rectum (66.11 ± 3.99 Gy vs. 66.46 ± 4.00 Gy, P = 0.542), bladder (78.28 ± 5.16 Gy vs. 79.45 ± 4.47 Gy, P = 0.201), and sigmoid (63.30 ± 4.86 Gy vs. 62.33 ± 6.84 Gy, P = 0.916). The algorithm significantly reduced the average number of needles from 5.40 ± 0.94 to 4.25 ± 0.55 (P < 0.001). The most substantial improvement was observed in one case (Patient 2), where the needle count was reduced from 7 to 4 while maintaining a coverage of 91.7%. The total planning workflow time was substantially reduced from 2 to 3 h (manual) to 8.2 ± 1.4 min (GANTP), with algorithm execution taking less than 190 s across all δ settings. CONCLUSION: GANTP establishes a semi-automated, patient-specific framework for generating collision-free, non-coplanar trajectories that meet clinical dosimetric goals with a reduced mean number of needles. Integrated with 3D-printed templates, this approach demonstrates significant potential for improving the precision and efficiency of interstitial brachytherapy. Future work will include phantom experiments for physical validation.
引用
- Shen J, Sun S, Xu Z, et al. A rapid semi-automated trajectory planning method for non-coplanar interstitial brachytherapy in cervical cancer using a greedy algorithm. Radiat Oncol. 2026. PMID: 42337636. doi:10.1186/s13014-026-02881-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。